FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
NHS 'blacklisted' 36 conditions and bans prescriptions for treatment
NHS England has ‘blacklisted’ 36 health conditions which cannot be treated with prescriptions and must instead be bought over ...